Precise, high-dose radiation safe and effective for inoperable kidney cancer, study suggests
A new study published in The Lancet Oncology suggests that a very precise, high-dose form of radiotherapy called stereotactic ablative radiotherapy (SABR) may be a new treatment option for patients with inoperable kidney cancer.
Donate now
Every day, hospital-based research in London, Ontario changes the lives of people around the world. Through close proximity to patients, scientists in the hospital can identify challenges and develop solutions effectively and then deliver them to care faster than anywhere else.
Why do Research with Lawson?
Lawson Health Research Institute has been driving innovation and helping to transform health care. Taking a “bench to bedside” approach to medical research, researchers focus their efforts on the development of new knowledge that can be applied directly to patient care. The fast pace of scientific discovery makes medical research an exciting place to be. Learn more about our current studies and how you can be a part of new groundbreaking research.
